3 November 2022
| Stephen O’Leary, Michael Tong (Prof), Metin Önerci (Prof), Manuel Bernal-Sprekelsen (Prof), Tatsuya Yamasoba (Prof)
|
ENTA - Audiology - Adult
As Dubai prepares to host IFOS 2023, the next IFOS congress in 2026 is already being planned. The competition to host the meeting is certain to be fierce – we hear from the organisers around the world bidding to bring...
Congenital deafness in China affects more people than the entire population of Australia. Prof Wang give us a comprehensive insight into one of the main congenital disabilities in China, looking into the causes of deafness and the benefits of genetic...
The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....
1 January 2019
| Cem Meco (Prof), Ricard Simo
|
ENTA - ENT
‘Together we are strong’ just about sums up the nature of the CEORL-HNS, with international and interdisciplinary collaboration at the forefront of its mission. We hear more from two of the leading lights of the organisation. The Confederation of European...
We are delighted to introduce a stunning new cover series by Dyon Scheijen, a Maastricht-based clinical physicist-audiologist and artist fascinated by the psychology of hearing. Dyon explores the connection between audiology, acceptance and commitment therapy (ACT) and sound perception. He...
As we emerge from the impact of the COVID-19 pandemic on the first half of 2020, trainee colleagues will be looking to their future once again. Options may include fellowships, and we are delighted to have Dr Andrew Ma share...
Stories of the saints are often rather dark and unpleasant – and this is certainly the case with St Æbbe, as we hear from our roving historian, John Riddington Young. In two previous articles, we have discovered the fascinating stories...
We all know that ear symptoms include hearing loss, vertigo, tinnitus and otalgia, but did you know there are patron saints for all these symptoms? John Riddington Young shares an overview of the patron saints of the ear, inspired by...
Nature Communications Medicine has published the first peer reviewed, real-world analysis of U.S. patients treated with Lenire, the only FDA approved tinnitus treatment device of its kind. Results in the paper “Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for...
This Turkish laboratory animal-based study looked at the effects of alpha-lipoic acid on inflammation, oxidative status, and tissue integrity in an animal model of experimentally induced acute rhinosinusitis and to compare these effects with antibiotic treatment using cephalosporins. Alpha-lipoic acid...
T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...
Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...